SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $411,000 | +0.5% | 262,020 | +28.7% | 0.04% | +8.6% |
| Q2 2022 | $409,000 | -56.4% | 203,663 | +79.6% | 0.04% | -47.0% |
| Q1 2021 | $938,000 | -47.5% | 113,385 | -56.7% | 0.07% | -65.8% |
| Q4 2020 | $1,787,000 | +489.8% | 261,795 | +191.7% | 0.19% | +565.5% |
| Q4 2019 | $303,000 | +163.5% | 89,749 | +108.5% | 0.03% | +314.3% |
| Q2 2019 | $115,000 | -16.1% | 43,041 | +49.4% | 0.01% | -12.5% |
| Q1 2019 | $137,000 | -18.0% | 28,817 | -58.5% | 0.01% | -11.1% |
| Q4 2018 | $167,000 | -28.9% | 69,509 | +30.4% | 0.01% | -35.7% |
| Q3 2018 | $235,000 | +46.9% | 53,307 | +71.5% | 0.01% | +55.6% |
| Q1 2018 | $160,000 | +116.2% | 31,083 | -28.3% | 0.01% | +125.0% |
| Q3 2017 | $74,000 | +164.3% | 43,348 | +207.7% | 0.00% | 0.0% |
| Q2 2017 | $28,000 | – | 14,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |